Theranostic agents for PSMA positive cancers
Grant
US12582728B2
Kind: B2
Mar 24, 2026
Assignee
Memorial Sloan Kettering Cancer Center
Inventors
Naga Vara Kishore Pillarsetty, Teja Muralidhar Kalidindi, Sang Gyu Lee, Steven M. Larson, Jason S. Lewis, Serge Lyashchenko, Eva Burnazi
Abstract
The present disclosure provides compositions and methods for the detection and treatment of cancer. Specifically, the compositions of the present technology include novel radiohalogenated (e.g., radioiodinated) PSMA targeting agents and methods of using the same in diagnostic imaging as well as radiation therapy.
CPC Classifications
A61K 51/1045
A61K 33/243
A61K 49/0002
A61K 51/0497
A61P 35/00
Filing Date
2020-08-28
Application No.
17638512
Claims
19